NEW YORK (GenomeWeb News) – Epic Sciences, which is developing diagnostics to identify and characterize rare cells, said today it is collaborating with six drug manufacturers to develop companion diagnostic tools.
NEW YORK (GenomeWeb News) – The Smithsonian Institution's National Museum of Natural History will collaborate with the National Human Genome Research Institute to open an exhibit next year that will highlight human genomics at its museum on the National Mall, leaders from the two institutes said
Epizyme is hoping that its new partnership with Celgene International Sarl will bolster the development and commercialization of its pipeline of personalized treatments that inhibit histone methyltransferase enzymes associated with specific genetic alterations.
The goal is to use the test to enable targeted recruitment of patient populations and to stratify patients based on their mutational profile to identify those most likely to respond to Celgene's drug candidates.
Foundation's test will be used to hasten faster recruitment of target patient populations and for broad genetic characterization of trial enrollees to identify those most likely to respond to Celgene's drug candidates.
A total of six facilities comprising more than 2 million square feet are in New York's pipeline of life-sci space, according to the panelists who spoke at the New York Biotechnology Association's annual meeting this week.